For some non-myeloid malignancies with high-dose chemotherapy treatments, administration of granulocyte colony-stimulating factors (G-CSF) is recommended; however, the most effective timing is still under discussion [13]. The gene discussed is CSF3; the disease is myeloid neoplasm.